资讯

In this work, we investigate the potential of highly sulfated synthetic glycomimetics to act as inhibitors of viral binding/infection. Our results indicate that both long-chain glycopolymers and short ...
Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...
Results of the single dose azithromycin trials reviewed here demonstrate that this regimen is safe and effective and results in excellent compliance in children with uncomplicated AOM. In addition ...
Although prophylactic mastectomy is a highly invasive procedure, women select this surgery to lower their breast cancer risk. Some may be at high risk for breast cancer due to family history of ...
EUROPEAN surveillance data from 2022 show a sharp rise in antimicrobial resistance (AMR) in Neisseria gonorrhoeae, raising new concerns about treatment efficacy for this common sexually transmitted ...
Citation Mitra S, GardnerCE, MacLellanA, DisherT, StyrankoDM, Campbell-YeoM, KuhleS, JohnstonBC, DorlingJ.Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in ...
(RTTNews) - CSL (CSLLY, CSL.AX) announced that the U.S. Food and Drug Administration approved ANDEMBRY (garadacimab-gxii), the only treatment targeting factor XIIa for prophylactic use to prevent ...
KING OF PRUSSIA, Pa., June 16, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the U.S. Food and Drug Administration (FDA) approved ANDEMBRY ...
The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...
KING OF PRUSSIA, Pa., June 16, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the U.S. Food and Drug Administration (FDA) approved ANDEMBRY ® ...
A total of 220 eligible patients will be randomised (1:1) to receive either adjunctive azithromycin or single-dose cephalosporin 30 min before the incision. The evaluation criteria are the prevalence ...